Currently Viewing:
Newsroom
Currently Reading
Patients Using Medication for Migraine Still Have Unmet Treatment Needs, Survey Says
May 14, 2019 – Allison Inserro
Study Examines Link Between Psoriasis, Migraine
May 04, 2019 – Allison Inserro
Early Onset of Migraine May Predispose Patients to Increased Risk of Stroke
May 03, 2019 – Samantha DiGrande
Demographics, Characteristics of Youth Receiving Migraine Treatment at Infusion Center
April 26, 2019 – Allison Inserro
Study Calls for More Effective Prophylactic Treatments for Migraine
April 25, 2019 – Samantha DiGrande
Shoshana Lipson Explains How "CGRP & Migraine Community" Supports Patients
April 18, 2019
Evaluating Revefenacin as a Treatment for COPD
April 17, 2019 – Wallace Stephens
Study Finds Association Between Migraine, Fibromyalgia Onset
April 16, 2019 – Allison Inserro
5 Things About the Impact of Migraine on Work and Health
April 13, 2019 – Allison Inserro

Patients Using Medication for Migraine Still Have Unmet Treatment Needs, Survey Says

Allison Inserro
In a large survey of patients with migraine taking an oral, acute prescription migraine medication, most had unmet needs, according to survey results presented recently at the annual meeting of the American Academy of Neurology.
In a large survey of patients with migraine taking an oral, acute prescription migraine medication, most had unmet needs, according to survey results presented recently at the annual meeting of the American Academy of Neurology.

The data came from the Migraine in America Symptoms and Treatment (MAST) Study, a longitudinal, internet-based panel study of symptoms, approaches to management, and unmet treatment needs among US adults with migraine.

Using a sample of MAST study participants, this particular study described areas of unmet treatment needs and assessed rates of migraine-related disability.

A validated migraine screener used modified International Classification of Headache Disorders-3 beta criteria to identify adults with migraine. Respondents

averaging 1 or more headache day per month over the previous 3 months and those using acute oral migraine medications were included. They were excluded if they used nasal or injectable treatments.

Respondents submitted data about age, gender, race, income, employment, education, body mass index, health insurance, smoking status, marital status, medication use and response, migraine symptoms, and migraine-related disability.

Fifteen characteristics of “unmet needs” were grouped into 3 domains based on item face validity and clinician judgment (inadequate treatment response, demanding attack characteristics, and unique patient characteristics).  Researchers also administered the 13-item MAST Unmet Treatment Needs questionnaire.

Among 15,133 respondents with migraine, 26% (n = 3930) reported use of oral acute prescription medications. The oral prescription sample had a mean [SD] age of 45 [13.5] years. Nearly 75% were women and most were white.

The majority of respondents had at least 1 unmet need (95.8%), reported unmet needs related to demanding attack characteristics (89.5%), or had unmet needs related to inadequate treatment response (74.1%). But only 16.1% reported unique patient characteristic unmet needs.

Common unmet needs included rapid onset of headache (65.3%), headache-related disability (55.6%), inadequate 2-hour pain freedom (49%), and pain recurrence within 24 hours (38.6%).

The MAST study is sponsored by Promius Pharma, maker of a sumatriptan nasal spray for migraine. 

Reference

Reed M, Lipton R, Munjal S, et al. Assessing unmet treatment needs and associated disability in persons with migraine: results from Migraine in America Symptoms and Treatment (MAST) study. Presented at: 71st American Academy of Neurology Annual Meeting (AAN); May 4-10, 2019; Philadelphia, PA.

Related Articles

Utilizing Mobile Health Technology to Improve Migraine Care
Headache Specialists Dissatisfied With Migraine Care in the ED
Review Find Moderate Evidence That Aerobic Exercise Lowers Number of Migraine Days
Study Calls for More Effective Prophylactic Treatments for Migraine
Study Suggests Benefit to Integrating Care for Migraine, Depression
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up